| Year |
Citation |
Score |
| 2024 |
Gomes I, Gupta A, Margolis EB, Fricker LD, Devi LA. . Molecular Pharmacology. PMID 39187388 DOI: 10.1124/molpharm.124.000947 |
0.423 |
|
| 2024 |
Gupta A, Gomes I, Osman A, Fujita W, Devi LA. . The Journal of Pharmacology and Experimental Therapeutics. PMID 39103231 DOI: 10.1124/jpet.124.002187 |
0.372 |
|
| 2024 |
Dong C, Gowrishankar R, Jin Y, He XJ, Gupta A, Wang H, Sayar-Atasoy N, Flores RJ, Mahe K, Tjahjono N, Liang R, Marley A, Or Mizuno G, Lo DK, Sun Q, ... ... Devi LA, et al. Unlocking opioid neuropeptide dynamics with genetically encoded biosensors. Nature Neuroscience. PMID 39009835 DOI: 10.1038/s41593-024-01697-1 |
0.304 |
|
| 2023 |
Duarte ML, Wang M, Gomes I, Liu C, Sharma A, Fakira AK, Gupta A, Mack SM, Zhang B, Devi LA. . Molecular Pharmacology. PMID 37147110 DOI: 10.1124/molpharm.122.000641 |
0.773 |
|
| 2022 |
Sakloth F, Sanchez Reyes OB, Ruiz A, Nicolais A, Serafini RA, Pryce KD, Bertherat F, Torres Berrio A, Gomes I, Devi LA, Wacker D, Zachariou V. . Molecular Pharmacology. PMID 36310031 DOI: 10.1124/molpharm.122.000528 |
0.337 |
|
| 2022 |
Fricker LD, Lemos Duarte M, Jeltyi A, Lueptow L, Fakira AK, Tashima AK, Hochgeschwender U, Wetsel WC, Devi LA. Mice heterozygous for a null mutation of CPE show reduced expression of carboxypeptidase e mRNA and enzyme activity but normal physiology, behavior, and levels of neuropeptides. Brain Research. 1789: 147951. PMID 35618016 DOI: 10.1016/j.brainres.2022.147951 |
0.768 |
|
| 2022 |
Mack SM, Gomes I, Fakira AK, Duarte ML, Gupta A, Fricker L, Devi LA. . Molecular Pharmacology. PMID 35605991 DOI: 10.1124/molpharm.122.000487 |
0.789 |
|
| 2021 |
Fakira AK, Lueptow LM, Trimbake NA, Devi LA. PEN Receptor GPR83 in Anxiety-Like Behaviors: Differential Regulation in Global vs Amygdalar Knockdown. Frontiers in Neuroscience. 15: 675769. PMID 34512237 DOI: 10.3389/fnins.2021.675769 |
0.779 |
|
| 2021 |
Kunselman JM, Gupta A, Gomes I, Devi LA, Puthenveedu MA. Compartment-specific opioid receptor signaling is selectively modulated by different Dynorphin peptides. Elife. 10. PMID 33908346 DOI: 10.7554/eLife.60270 |
0.403 |
|
| 2021 |
Rae M, Duarte ML, Gomes I, Camarini R, Devi LA. Oxytocin and vasopressin: Signalling, behavioural modulation and potential therapeutic effects. British Journal of Pharmacology. PMID 33817785 DOI: 10.1111/bph.15481 |
0.329 |
|
| 2021 |
Gupta A, Gullapalli S, Pan H, Ramos-Ortolaza DL, Hayward MD, Low MJ, Pintar JE, Devi LA, Gomes I. Regulation of Opioid Receptors by Their Endogenous Opioid Peptides. Cellular and Molecular Neurobiology. PMID 33389463 DOI: 10.1007/s10571-020-01015-w |
0.385 |
|
| 2020 |
Fricker LD, Tashima AK, Fakira AK, Hochgeschwender U, Wetsel WC, Devi LA. Neuropeptidomic Analysis of a Genetically Defined Cell Type in Mouse Brain and Pituitary. Cell Chemical Biology. PMID 33217339 DOI: 10.1016/j.chembiol.2020.11.003 |
0.775 |
|
| 2020 |
Fakira AK, Devi LA, Kennedy PJ. Novel Application for G Protein-Biased Mu Opioid Receptor Agonists in Opioid Relapse Prevention. Biological Psychiatry. 88: 896-897. PMID 33213702 DOI: 10.1016/j.biopsych.2020.09.006 |
0.804 |
|
| 2020 |
Faouzi A, Uprety R, Gomes I, Massaly N, Keresztes AI, Le Rouzic V, Gupta A, Zhang T, Yoon HJ, Ansonoff M, Allaoa A, Pan YX, Pintar J, Morón JA, Streicher JM, ... Devi LA, et al. Synthesis and Pharmacology of a Novel μ-δ Opioid Receptor Heteromer-Selective Agonist Based on the Carfentanyl Template. Journal of Medicinal Chemistry. PMID 33170687 DOI: 10.1021/acs.jmedchem.0c00901 |
0.78 |
|
| 2020 |
Palma JA, Gupta A, Sierra S, Gomes I, Balgobin B, Norcliffe-Kaufmann L, Devi LA, Kaufmann H. Autoantibodies blocking M muscarinic receptors cause postganglionic cholinergic dysautonomia. Annals of Neurology. PMID 32833276 DOI: 10.1002/Ana.25882 |
0.35 |
|
| 2020 |
Fricker LD, Margolis E, Gomes I, Devi LA. Five decades of research on opioid peptides: Current knowledge and unanswered questions. Molecular Pharmacology. PMID 32487735 DOI: 10.1124/Mol.120.119388 |
0.469 |
|
| 2020 |
Lemos Duarte M, Devi LA. Post-translational Modifications of Opioid Receptors. Trends in Neurosciences. 43: 417-432. PMID 32459993 DOI: 10.1016/J.Tins.2020.03.011 |
0.511 |
|
| 2020 |
Gomes I, Sierra S, Lueptow L, Gupta A, Gouty S, Margolis EB, Cox BM, Devi LA. Biased signaling by endogenous opioid peptides. Proceedings of the National Academy of Sciences of the United States of America. PMID 32393639 DOI: 10.1073/Pnas.2000712117 |
0.506 |
|
| 2020 |
Sakloth F, Singh M, Serafini R, Gomes I, Devi L, Zachariou V. RGSz1 actions in the periaqueductal gray modulate opioid reward and analgesic tolerance The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.03381 |
0.366 |
|
| 2019 |
Tiwari V, He SQ, Huang Q, Liang L, Yang F, Chen Z, Tiwari V, Fujita W, Devi LA, Dong X, Guan Y, Raja SN. Activation of µ-δ opioid receptor heteromers inhibits neuropathic pain behavior in rodents. Pain. PMID 31815916 DOI: 10.1097/J.Pain.0000000000001768 |
0.392 |
|
| 2019 |
Sierra S, Gupta A, Gomes I, Fowkes M, Ram A, Bobeck EN, Devi LA. Targeting Cannabinoid 1 and Delta Opioid Receptor Heteromers Alleviates Chemotherapy-Induced Neuropathic Pain. Acs Pharmacology & Translational Science. 2: 219-229. PMID 31565698 DOI: 10.1021/acsptsci.9b00008 |
0.305 |
|
| 2019 |
McDermott MV, Afrose L, Gomes I, Devi LA, Bobeck EN. Opioid-induced signaling and antinociception are modulated by the recently deorphanized receptor, GPR171. The Journal of Pharmacology and Experimental Therapeutics. PMID 31308196 DOI: 10.1124/Jpet.119.259242 |
0.514 |
|
| 2019 |
Fakira AK, Peck EG, Liu Y, Lueptow LM, Trimbake NA, Han MH, Calipari ES, Devi LA. The role of the neuropeptide PEN receptor, GPR83, in the reward pathway: Relationship to sex-differences. Neuropharmacology. 107666. PMID 31199956 DOI: 10.1016/J.Neuropharm.2019.107666 |
0.777 |
|
| 2019 |
Mack SM, Gomes I, Devi LA. Neuropeptide PEN and its receptor GPR83; Distribution, Signaling and Regulation. Acs Chemical Neuroscience. PMID 30726666 DOI: 10.1021/Acschemneuro.8B00559 |
0.449 |
|
| 2019 |
Borsodi A, Bruchas M, Caló G, Chavkin C, Christie MJ, Civelli O, Connor M, Cox BM, Devi LA, Evans C, Höllt V, Henderson G, Husbands S, Kelly E, Kieffer B, et al. Opioid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database Iuphar/Bps Guide to Pharmacology Cite. 2019. DOI: 10.2218/gtopdb/f50/2019.4 |
0.36 |
|
| 2018 |
Majumdar S, Devi LA. Strategy for making safer opioids bolstered. Nature. 553: 286-288. PMID 32076275 DOI: 10.1038/D41586-018-00045-1 |
0.446 |
|
| 2018 |
Fujita W, Yokote M, Gomes I, Gupta A, Ueda H, Devi LA. Regulation of a opioid receptor chaperone protein, RTP4, by morphine. Molecular Pharmacology. PMID 30348895 DOI: 10.1124/Mol.118.112987 |
0.503 |
|
| 2018 |
Lueptow LM, Devi LA, Fakira AK. Targeting the Recently Deorphanized Receptor GPR83 for the Treatment of Immunological, Neuroendocrine and Neuropsychiatric Disorders. Progress in Molecular Biology and Translational Science. 159: 1-25. PMID 30340784 DOI: 10.1016/Bs.Pmbts.2018.07.002 |
0.804 |
|
| 2018 |
Pena DA, Duarte ML, Pramio DT, Devi LA, Schechtman D. Exploring Morphine-Triggered PKC-Targets and Their Interaction with Signaling Pathways Leading to Pain via TrkA. Proteomes. 6. PMID 30301203 DOI: 10.3390/Proteomes6040039 |
0.49 |
|
| 2018 |
Heimann AS, Gupta A, Gomes I, Rahman R, Schlessinger A, Ferro ES, Unterwald EM, Devi LA. Correction: Generation of G protein-coupled receptor antibodies differentially sensitive to conformational states. Plos One. 13: e0193322. PMID 29447277 DOI: 10.1371/Journal.Pone.0193322 |
0.326 |
|
| 2017 |
Fricker LD, Devi LA. Orphan neuropeptides and receptors: Novel therapeutic targets. Pharmacology & Therapeutics. PMID 29174650 DOI: 10.1016/J.Pharmthera.2017.11.006 |
0.477 |
|
| 2017 |
Reckziegel P, Festuccia WT, Britto LRG, Jang KLL, Romão CM, Heimann JC, Fogaça MV, Rodrigues NS, Silva NR, Guimarães FS, Eichler RAS, Gupta A, Gomes I, Devi LA, Heimann AS, et al. A novel peptide that improves metabolic parameters without adverse central nervous system effects. Scientific Reports. 7: 14781. PMID 29093454 DOI: 10.1038/S41598-017-13690-9 |
0.458 |
|
| 2017 |
Heimann AS, Gupta A, Gomes I, Rayees R, Schlessinger A, Ferro ES, Unterwald EM, Devi LA. Generation of G protein-coupled receptor antibodies differentially sensitive to conformational states. Plos One. 12: e0187306. PMID 29091950 DOI: 10.1371/journal.pone.0187306 |
0.3 |
|
| 2017 |
Margolis EB, Fujita W, Devi LA, Fields HL. Two delta opioid receptor subtypes are functional in single ventral tegmental area neurons, and can interact with the mu opioid receptor. Neuropharmacology. PMID 28645621 DOI: 10.1016/J.Neuropharm.2017.06.019 |
0.418 |
|
| 2017 |
Bobeck EN, Gomes I, Pena D, Cummings KA, Clem RL, Mezei M, Devi LA. The BigLEN-GPR171 Peptide Receptor System within the Basolateral Amygdala Regulates Anxiety-Like Behavior and Contextual Fear Conditioning. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28425495 DOI: 10.1038/Npp.2017.79 |
0.359 |
|
| 2016 |
Gomes I, Sierra S, Devi LA. Detection of Receptor Heteromerization Using In Situ Proximity Ligation Assay. Current Protocols in Pharmacology. 75: 2.16.1-2.16.31. PMID 27960030 DOI: 10.1002/Cpph.15 |
0.435 |
|
| 2016 |
Wardman JH, Gomes I, Bobeck EN, Stockert JA, Kapoor A, Bisignano P, Gupta A, Mezei M, Kumar S, Filizola M, Devi LA. Identification of a small-molecule ligand that activates the neuropeptide receptor GPR171 and increases food intake. Science Signaling. 9: ra55. PMID 27245612 DOI: 10.1126/Scisignal.Aac8035 |
0.384 |
|
| 2016 |
Gupta A, Gomes I, Bobeck EN, Fakira AK, Massaro NP, Sharma I, Cavé A, Hamm HE, Parello J, Devi LA. Collybolide is a novel biased agonist of κ-opioid receptors with potent antipruritic activity. Proceedings of the National Academy of Sciences of the United States of America. PMID 27162327 DOI: 10.1073/Pnas.1521825113 |
0.809 |
|
| 2016 |
Gomes I, Bobeck EN, Margolis EB, Gupta A, Sierra S, Fakira AK, Fujita W, Müller TD, Müller A, Tschöp MH, Kleinau G, Fricker LD, Devi LA. Identification of GPR83 as the receptor for the neuroendocrine peptide PEN. Science Signaling. 9: ra43. PMID 27117253 DOI: 10.1126/Scisignal.Aad0694 |
0.81 |
|
| 2016 |
Pena DA, Andrade VP, Silva GÁ, Neves JI, Oliveira PS, Alves MJ, Devi LA, Schechtman D. Rational design and validation of an anti-protein kinase C active-state specific antibody based on conformational changes. Scientific Reports. 6: 22114. PMID 26911897 DOI: 10.1038/Srep22114 |
0.326 |
|
| 2016 |
Gomes I, Ayoub MA, Fujita W, Jaeger WC, Pfleger KD, Devi LA. G Protein-Coupled Receptor Heteromers. Annual Review of Pharmacology and Toxicology. 56: 403-25. PMID 26514203 DOI: 10.1146/Annurev-Pharmtox-011613-135952 |
0.444 |
|
| 2015 |
Stockton SD, Gomes I, Liu T, Moraje C, Hipólito L, Jones MR, Ma'ayan A, Morón JA, Li H, Devi LA. Morphine Regulated Synaptic Networks Revealed by Integrated Proteomics and Network Analysis. Molecular & Cellular Proteomics : McP. PMID 26149443 DOI: 10.1074/Mcp.M115.047977 |
0.8 |
|
| 2015 |
Stockert JA, Devi LA. Advancements in therapeutically targeting orphan GPCRs. Frontiers in Pharmacology. 6: 100. PMID 26005419 DOI: 10.3389/Fphar.2015.00100 |
0.408 |
|
| 2015 |
Fujita W, Gomes I, Devi LA. Heteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities. British Journal of Pharmacology. 172: 375-87. PMID 24571499 DOI: 10.1111/Bph.12663 |
0.518 |
|
| 2015 |
Cox BM, Christie MJ, Devi L, Toll L, Traynor JR. Challenges for opioid receptor nomenclature: IUPHAR Review 9. British Journal of Pharmacology. 172: 317-23. PMID 24528283 DOI: 10.1111/Bph.12612 |
0.491 |
|
| 2015 |
Gupta A, Fujita W, Gomes I, Bobeck E, Devi LA. Endothelin-converting enzyme 2 differentially regulates opioid receptor activity British Journal of Pharmacology. 172: 704-719. DOI: 10.1111/Bph.12833 |
0.518 |
|
| 2014 |
Gomes I, Gupta A, Bushlin I, Devi LA. Antibodies to probe endogenous G protein-coupled receptor heteromer expression, regulation, and function. Frontiers in Pharmacology. 5: 268. PMID 25520661 DOI: 10.3389/Fphar.2014.00268 |
0.462 |
|
| 2014 |
Fujita W, Gomes I, Dove LS, Prohaska D, McIntyre G, Devi LA. Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers. Biochemical Pharmacology. 92: 448-56. PMID 25261794 DOI: 10.1016/J.Bcp.2014.09.015 |
0.49 |
|
| 2014 |
Kivell B, Uzelac Z, Sundaramurthy S, Rajamanickam J, Ewald A, Chefer V, Jaligam V, Bolan E, Simonson B, Annamalai B, Mannangatti P, Prisinzano TE, Gomes I, Devi LA, Jayanthi LD, et al. Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism. Neuropharmacology. 86: 228-40. PMID 25107591 DOI: 10.1016/J.Neuropharm.2014.07.016 |
0.591 |
|
| 2014 |
Fujita W, Gomes I, Devi LA. Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10. British Journal of Pharmacology. 171: 4155-76. PMID 24916280 DOI: 10.1111/Bph.12798 |
0.511 |
|
| 2014 |
Gupta A, Gomes I, Wardman J, Devi LA. Opioid receptor function is regulated by post-endocytic peptide processing. The Journal of Biological Chemistry. 289: 19613-26. PMID 24847082 DOI: 10.1074/Jbc.M113.537704 |
0.504 |
|
| 2014 |
Toniolo EF, Maique ET, Ferreira WA, Heimann AS, Ferro ES, Ramos-Ortolaza DL, Miller L, Devi LA, Dale CS. Hemopressin, an inverse agonist of cannabinoid receptors, inhibits neuropathic pain in rats. Peptides. 56: 125-31. PMID 24703998 DOI: 10.1016/J.Peptides.2014.03.016 |
0.391 |
|
| 2014 |
Ferré S, Casadó V, Devi LA, Filizola M, Jockers R, Lohse MJ, Milligan G, Pin JP, Guitart X. G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives. Pharmacological Reviews. 66: 413-34. PMID 24515647 DOI: 10.1124/Pr.113.008052 |
0.419 |
|
| 2014 |
Matsumoto K, Narita M, Muramatsu N, Nakayama T, Misawa K, Kitajima M, Tashima K, Devi LA, Suzuki T, Takayama H, Horie S. Orally Active opioid μ/δ dual agonist MGM-16, a derivative of the indole alkaloid mitragynine, exhibits potent antiallodynic effect on neuropathic pain in mices Journal of Pharmacology and Experimental Therapeutics. 348: 383-392. PMID 24345467 DOI: 10.1124/Jpet.113.208108 |
0.402 |
|
| 2014 |
Stockton SD, Devi LA. An integrated quantitative proteomics and systems biology approach to explore synaptic protein profile changes during morphine exposure. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 88-103. PMID 24045585 DOI: 10.1038/Npp.2013.227 |
0.793 |
|
| 2013 |
Gomes I, Aryal DK, Wardman JH, Gupta A, Gagnidze K, Rodriguiz RM, Kumar S, Wetsel WC, Pintar JE, Fricker LD, Devi LA. GPR171 is a hypothalamic G protein-coupled receptor for BigLEN, a neuropeptide involved in feeding. Proceedings of the National Academy of Sciences of the United States of America. 110: 16211-6. PMID 24043826 DOI: 10.1073/Pnas.1312938110 |
0.776 |
|
| 2013 |
Gomes I, Fujita W, Gupta A, Saldanha SA, Saldanha AS, Negri A, Pinello CE, Eberhart C, Roberts E, Filizola M, Hodder P, Devi LA. Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptive activity. Proceedings of the National Academy of Sciences of the United States of America. 110: 12072-7. PMID 23818586 DOI: 10.1073/Pnas.1222044110 |
0.523 |
|
| 2013 |
Gomes I, Fujita W, Chandrakala MV, Devi LA. Disease-specific heteromerization of G-protein-coupled receptors that target drugs of abuse. Progress in Molecular Biology and Translational Science. 117: 207-65. PMID 23663971 DOI: 10.1016/B978-0-12-386931-9.00009-X |
0.495 |
|
| 2013 |
Gomes I, Gupta A, Devi LA. G-protein-coupled heteromers: regulation in disease. Methods in Enzymology. 521: 219-38. PMID 23351742 DOI: 10.1016/B978-0-12-391862-8.00012-0 |
0.471 |
|
| 2013 |
Filizola M, Devi LA. Grand opening of structure-guided design for novel opioids. Trends in Pharmacological Sciences. 34: 6-12. PMID 23127545 DOI: 10.1016/J.Tips.2012.10.002 |
0.421 |
|
| 2013 |
Narita M, Imai S, Nakamura A, Ozeki A, Asato M, Rahmadi M, Sudo Y, Hojo M, Uezono Y, Devi LA, Kuzumaki N, Suzuki T. Possible involvement of prolonging spinal μ-opioid receptor desensitization in the development of antihyperalgesic tolerance to μ-opioids under a neuropathic pain-like state Addiction Biology. 18: 614-622. PMID 21812868 DOI: 10.1111/J.1369-1600.2011.00354.X |
0.406 |
|
| 2012 |
Bushlin I, Gupta A, Stockton SD, Miller LK, Devi LA. Dimerization with cannabinoid receptors allosterically modulates delta opioid receptor activity during neuropathic pain. Plos One. 7: e49789. PMID 23272051 DOI: 10.1371/Journal.Pone.0049789 |
0.814 |
|
| 2012 |
Filizola M, Devi LA. Structural biology: How opioid drugs bind to receptors. Nature. 485: 314-7. PMID 22596150 DOI: 10.1038/485314A |
0.466 |
|
| 2012 |
Costantino CM, Gomes I, Stockton SD, Lim MP, Devi LA. Opioid receptor heteromers in analgesia. Expert Reviews in Molecular Medicine. 14: e9. PMID 22490239 DOI: 10.1017/Erm.2012.5 |
0.82 |
|
| 2012 |
Costantino CM, Gupta A, Yewdall AW, Dale BM, Devi LA, Chen BK. Cannabinoid receptor 2-mediated attenuation of CXCR4-tropic HIV infection in primary CD4+ T cells. Plos One. 7: e33961. PMID 22448282 DOI: 10.1371/Journal.Pone.0033961 |
0.337 |
|
| 2012 |
Rozenfeld R, Bushlin I, Gomes I, Tzavaras N, Gupta A, Neves S, Battini L, Gusella GL, Lachmann A, Ma'ayan A, Blitzer RD, Devi LA. Receptor heteromerization expands the repertoire of cannabinoid signaling in rodent neurons. Plos One. 7: e29239. PMID 22235275 DOI: 10.1371/Journal.Pone.0029239 |
0.428 |
|
| 2012 |
Stockton SD, Devi LA. Functional relevance of μ-δ opioid receptor heteromerization: a role in novel signaling and implications for the treatment of addiction disorders: from a symposium on new concepts in mu-opioid pharmacology. Drug and Alcohol Dependence. 121: 167-72. PMID 22115888 DOI: 10.1016/J.Drugalcdep.2011.10.025 |
0.812 |
|
| 2012 |
Berg KA, Rowan MP, Gupta A, Sanchez TA, Silva M, Gomes I, McGuire BA, Portoghese PS, Hargreaves KM, Devi LA, Clarke WP. Allosteric interactions between δ and κ opioid receptors in peripheral sensory neurons. Molecular Pharmacology. 81: 264-72. PMID 22072818 DOI: 10.1124/Mol.111.072702 |
0.425 |
|
| 2011 |
Abul-Husn NS, Annangudi SP, Ma'ayan A, Ramos-Ortolaza DL, Stockton SD, Gomes I, Sweedler JV, Devi LA. Chronic morphine alters the presynaptic protein profile: identification of novel molecular targets using proteomics and network analysis. Plos One. 6: e25535. PMID 22043286 DOI: 10.1371/Journal.Pone.0025535 |
0.787 |
|
| 2011 |
Miller LK, Hou X, Rodriguiz RM, Gagnidze K, Sweedler JV, Wetsel WC, Devi LA. Mice deficient in endothelin-converting enzyme-2 exhibit abnormal responses to morphine and altered peptide levels in the spinal cord. Journal of Neurochemistry. 119: 1074-85. PMID 21972895 DOI: 10.1111/J.1471-4159.2011.07513.X |
0.741 |
|
| 2011 |
Miller LK, Devi LA. The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications. Pharmacological Reviews. 63: 461-70. PMID 21752875 DOI: 10.1124/Pr.110.003491 |
0.418 |
|
| 2011 |
Gupta A, Devi LA, Gomes I. Potentiation of μ-opioid receptor-mediated signaling by ketamine. Journal of Neurochemistry. 119: 294-302. PMID 21692801 DOI: 10.1111/J.1471-4159.2011.07361.X |
0.469 |
|
| 2011 |
Rozenfeld R, Gupta A, Gagnidze K, Lim MP, Gomes I, Lee-Ramos D, Nieto N, Devi LA. AT1R-CB₁R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II. The Embo Journal. 30: 2350-63. PMID 21540834 DOI: 10.1038/Emboj.2011.139 |
0.755 |
|
| 2011 |
Imai S, Sudo Y, Nakamura A, Ozeki A, Asato M, Hojo M, Devi LA, Kuzumaki N, Suzuki T, Uezono Y, Narita M. Possible involvement of β-endorphin in a loss of the coordinated balance of μ-opioid receptors trafficking processes by fentanyl. Synapse (New York, N.Y.). 65: 962-6. PMID 21437993 DOI: 10.1002/Syn.20930 |
0.409 |
|
| 2011 |
Gomes I, Ijzerman AP, Ye K, Maillet EL, Devi LA. G protein-coupled receptor heteromerization: a role in allosteric modulation of ligand binding. Molecular Pharmacology. 79: 1044-52. PMID 21415307 DOI: 10.1124/Mol.110.070847 |
0.446 |
|
| 2011 |
Golebiewska U, Johnston JM, Devi L, Filizola M, Scarlata S. Differential response to morphine of the oligomeric state of μ-opioid in the presence of δ-opioid receptors. Biochemistry. 50: 2829-37. PMID 21361347 DOI: 10.1021/Bi101701X |
0.457 |
|
| 2011 |
Rozenfeld R, Devi LA. Exploring a role for heteromerization in GPCR signalling specificity. The Biochemical Journal. 433: 11-8. PMID 21158738 DOI: 10.1042/Bj20100458 |
0.452 |
|
| 2010 |
Ouimet T, Orng SV, Poras H, Gagnidze K, Devi LA, Fournié-Zaluski MC, Roques BP. Identification of an endothelin-converting enzyme-2-specific fluorigenic substrate and development of an in vitro and ex vivo enzymatic assay. The Journal of Biological Chemistry. 285: 34390-400. PMID 20807771 DOI: 10.1074/Jbc.M110.120576 |
0.714 |
|
| 2010 |
LaRocca TJ, Schwarzkopf M, Altman P, Zhang S, Gupta A, Gomes I, Alvin Z, Champion HC, Haddad G, Hajjar RJ, Devi LA, Schecter AD, Tarzami ST. β2-Adrenergic receptor signaling in the cardiac myocyte is modulated by interactions with CXCR4. Journal of Cardiovascular Pharmacology. 56: 548-59. PMID 20729750 DOI: 10.1097/Fjc.0B013E3181F713Fe |
0.401 |
|
| 2010 |
Williams D, Devi LA. Escorts take the lead molecular chaperones as therapeutic targets. Progress in Molecular Biology and Translational Science. 91: 121-49. PMID 20691961 DOI: 10.1016/S1877-1173(10)91005-3 |
0.445 |
|
| 2010 |
Hipser C, Bushlin I, Gupta A, Gomes I, Devi LA. Role of antibodies in developing drugs that target G-protein-coupled receptor dimers. The Mount Sinai Journal of Medicine, New York. 77: 374-80. PMID 20687183 DOI: 10.1002/Msj.20199 |
0.425 |
|
| 2010 |
Gupta A, Mulder J, Gomes I, Rozenfeld R, Bushlin I, Ong E, Lim M, Maillet E, Junek M, Cahill CM, Harkany T, Devi LA. Increased abundance of opioid receptor heteromers after chronic morphine administration. Science Signaling. 3: ra54. PMID 20647592 DOI: 10.1126/Scisignal.2000807 |
0.456 |
|
| 2010 |
Khelashvili G, Dorff K, Shan J, Camacho-Artacho M, Skrabanek L, Vroling B, Bouvier M, Devi LA, George SR, Javitch JA, Lohse MJ, Milligan G, Neubig RR, Palczewski K, Parmentier M, et al. GPCR-OKB: the G Protein Coupled Receptor Oligomer Knowledge Base. Bioinformatics (Oxford, England). 26: 1804-5. PMID 20501551 DOI: 10.1093/Bioinformatics/Btq264 |
0.372 |
|
| 2010 |
Morgan DJ, Wei S, Gomes I, Czyzyk T, Mzhavia N, Pan H, Devi LA, Fricker LD, Pintar JE. The propeptide precursor proSAAS is involved in fetal neuropeptide processing and body weight regulation. Journal of Neurochemistry. 113: 1275-84. PMID 20367757 DOI: 10.1111/J.1471-4159.2010.06706.X |
0.333 |
|
| 2010 |
Rozenfeld R, Devi LA. Receptor heteromerization and drug discovery. Trends in Pharmacological Sciences. 31: 124-30. PMID 20060175 DOI: 10.1016/J.Tips.2009.11.008 |
0.456 |
|
| 2010 |
Ramos-Ortolaza DL, Bushlin I, Abul-Husn N, Annangudi SP, Sweedler J, Devi LA. Quantitative neuroproteomics of the synapse. Methods in Molecular Biology (Clifton, N.J.). 615: 227-46. PMID 20013213 DOI: 10.1007/978-1-60761-535-4_18 |
0.623 |
|
| 2010 |
Morón JA, Gullapalli S, Taylor C, Gupta A, Gomes I, Devi LA. Modulation of opiate-related signaling molecules in morphine-dependent conditioned behavior: conditioned place preference to morphine induces CREB phosphorylation. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 955-66. PMID 19956087 DOI: 10.1038/Npp.2009.199 |
0.432 |
|
| 2010 |
Bushlin I, Rozenfeld R, Devi LA. Cannabinoid-opioid interactions during neuropathic pain and analgesia. Current Opinion in Pharmacology. 10: 80-6. PMID 19857996 DOI: 10.1016/J.Coph.2009.09.009 |
0.478 |
|
| 2009 |
Miller J, Agarwal A, Devi LA, Fontanini K, Hamilton JA, Pin JP, Shields DC, Spek CA, Sakmar TP, Kuliopulos A, Hunt SW. Insider access: pepducin symposium explores a new approach to GPCR modulation. Annals of the New York Academy of Sciences. 1180: E1-12. PMID 19925639 DOI: 10.1111/J.1749-6632.2009.05326.X |
0.42 |
|
| 2009 |
Abul-Husn NS, Bushlin I, Morón JA, Jenkins SL, Dolios G, Wang R, Iyengar R, Ma'ayan A, Devi LA. Systems approach to explore components and interactions in the presynapse. Proteomics. 9: 3303-15. PMID 19562802 DOI: 10.1002/Pmic.200800767 |
0.622 |
|
| 2009 |
Gomes I, Grushko JS, Golebiewska U, Hoogendoorn S, Gupta A, Heimann AS, Ferro ES, Scarlata S, Fricker LD, Devi LA. Novel endogenous peptide agonists of cannabinoid receptors. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 3020-9. PMID 19380512 DOI: 10.1096/Fj.09-132142 |
0.443 |
|
| 2009 |
Alfaras-Melainis K, Gomes I, Rozenfeld R, Zachariou V, Devi L. Modulation of opioid receptor function by protein-protein interactions. Frontiers in Bioscience (Landmark Edition). 14: 3594-607. PMID 19273296 DOI: 10.2735/3474 |
0.414 |
|
| 2009 |
Ferré S, Baler R, Bouvier M, Caron MG, Devi LA, Durroux T, Fuxe K, George SR, Javitch JA, Lohse MJ, Mackie K, Milligan G, Pfleger KD, Pin JP, Volkow ND, et al. Building a new conceptual framework for receptor heteromers. Nature Chemical Biology. 5: 131-4. PMID 19219011 DOI: 10.1038/Nchembio0309-131 |
0.363 |
|
| 2008 |
Décaillot FM, Rozenfeld R, Gupta A, Devi LA. Cell surface targeting of mu-delta opioid receptor heterodimers by RTP4. Proceedings of the National Academy of Sciences of the United States of America. 105: 16045-50. PMID 18836069 DOI: 10.1073/Pnas.0804106105 |
0.509 |
|
| 2008 |
Ellgren M, Artmann A, Tkalych O, Gupta A, Hansen HS, Hansen SH, Devi LA, Hurd YL. Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 18: 826-34. PMID 18674887 DOI: 10.1016/J.Euroneuro.2008.06.009 |
0.312 |
|
| 2008 |
Gupta A, Heimann AS, Gomes I, Devi LA. Antibodies against G-protein coupled receptors: novel uses in screening and drug development. Combinatorial Chemistry & High Throughput Screening. 11: 463-7. PMID 18673273 DOI: 10.2174/138620708784911465 |
0.323 |
|
| 2008 |
Gagnidze K, Sachchidanand, Rozenfeld R, Mezei M, Zhou MM, Devi LA. Homology modeling and site-directed mutagenesis to identify selective inhibitors of endothelin-converting enzyme-2. Journal of Medicinal Chemistry. 51: 3378-87. PMID 18507370 DOI: 10.1021/Jm7015478 |
0.708 |
|
| 2008 |
Charlton JJ, Allen PB, Psifogeorgou K, Chakravarty S, Gomes I, Neve RL, Devi LA, Greengard P, Nestler EJ, Zachariou V. Multiple actions of spinophilin regulate mu opioid receptor function. Neuron. 58: 238-47. PMID 18439408 DOI: 10.1016/J.Neuron.2008.02.006 |
0.482 |
|
| 2008 |
Rozenfeld R, Devi LA. Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 2311-22. PMID 18267983 DOI: 10.1096/Fj.07-102731 |
0.446 |
|
| 2008 |
Gupta A, Rozenfeld R, Gomes I, Raehal KM, Décaillot FM, Bohn LM, Devi LA. Post-activation-mediated changes in opioid receptors detected by N-terminal antibodies. The Journal of Biological Chemistry. 283: 10735-44. PMID 18256033 DOI: 10.1074/Jbc.M709454200 |
0.4 |
|
| 2008 |
Devi L, Petanceska S, Liu R, Arbabha B, Bansinath M, Garg U. Regulation of neuropeptide-processing enzymes by nitric oxide in cultured astrocytes. Journal of Neurochemistry. 62: 2387-2393. PMID 8189243 DOI: 10.1046/J.1471-4159.1994.62062387.X |
0.317 |
|
| 2007 |
Heimann AS, Gomes I, Dale CS, Pagano RL, Gupta A, de Souza LL, Luchessi AD, Castro LM, Giorgi R, Rioli V, Ferro ES, Devi LA. Hemopressin is an inverse agonist of CB1 cannabinoid receptors. Proceedings of the National Academy of Sciences of the United States of America. 104: 20588-93. PMID 18077343 DOI: 10.1073/Pnas.0706980105 |
0.479 |
|
| 2007 |
Rozenfeld R, Abul-Husn NS, Gomez I, Devi LA. An emerging role for the delta opioid receptor in the regulation of mu opioid receptor function. Thescientificworldjournal. 7: 64-73. PMID 17982578 DOI: 10.1100/Tsw.2007.219 |
0.708 |
|
| 2007 |
Skrabanek L, Murcia M, Bouvier M, Devi L, George SR, Lohse MJ, Milligan G, Neubig R, Palczewski K, Parmentier M, Pin JP, Vriend G, Javitch JA, Campagne F, Filizola M. Requirements and ontology for a G protein-coupled receptor oligomerization knowledge base. Bmc Bioinformatics. 8: 177. PMID 17537266 DOI: 10.1186/1471-2105-8-177 |
0.341 |
|
| 2007 |
Morón JA, Devi LA. Use of proteomics for the identification of novel drug targets in brain diseases. Journal of Neurochemistry. 102: 306-15. PMID 17419802 DOI: 10.1111/J.1471-4159.2007.04536.X |
0.305 |
|
| 2007 |
Rozenfeld R, Devi LA. Receptor heterodimerization leads to a switch in signaling: beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimers. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 21: 2455-65. PMID 17384143 DOI: 10.1096/Fj.06-7793Com |
0.425 |
|
| 2007 |
Pin JP, Neubig R, Bouvier M, Devi L, Filizola M, Javitch JA, Lohse MJ, Milligan G, Palczewski K, Parmentier M, Spedding M. International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers. Pharmacological Reviews. 59: 5-13. PMID 17329545 DOI: 10.1124/Pr.59.1.5 |
0.413 |
|
| 2007 |
Bolan EA, Kivell B, Jaligam V, Oz M, Jayanthi LD, Han Y, Sen N, Urizar E, Gomes I, Devi LA, Ramamoorthy S, Javitch JA, Zapata A, Shippenberg TS. D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Molecular Pharmacology. 71: 1222-32. PMID 17267664 DOI: 10.1124/Mol.106.027763 |
0.568 |
|
| 2007 |
Harkany T, Guzmán M, Galve-Roperh I, Berghuis P, Devi LA, Mackie K. The emerging functions of endocannabinoid signaling during CNS development. Trends in Pharmacological Sciences. 28: 83-92. PMID 17222464 DOI: 10.1016/J.Tips.2006.12.004 |
0.316 |
|
| 2007 |
Gupta A, Décaillot FM, Gomes I, Tkalych O, Heimann AS, Ferro ES, Devi LA. Conformation state-sensitive antibodies to G-protein-coupled receptors. The Journal of Biological Chemistry. 282: 5116-24. PMID 17148456 DOI: 10.1074/Jbc.M609254200 |
0.433 |
|
| 2007 |
Gendron L, Esdaile MJ, Mennicken F, Pan H, O'Donnell D, Vincent JP, Devi LA, Cahill CM, Stroh T, Beaudet A. Morphine priming in rats with chronic inflammation reveals a dichotomy between antihyperalgesic and antinociceptive properties of deltorphin. Neuroscience. 144: 263-74. PMID 17055663 DOI: 10.1016/J.Neuroscience.2006.08.077 |
0.364 |
|
| 2007 |
Morón JA, Abul-Husn NS, Rozenfeld R, Dolios G, Wang R, Devi LA. Morphine administration alters the profile of hippocampal postsynaptic density-associated proteins: a proteomics study focusing on endocytic proteins. Molecular & Cellular Proteomics : McP. 6: 29-42. PMID 17028301 DOI: 10.1074/Mcp.M600184-Mcp200 |
0.669 |
|
| 2006 |
Gupta A, Devi LA. The use of receptor-specific antibodies to study G-protein-coupled receptors. The Mount Sinai Journal of Medicine, New York. 73: 673-81. PMID 16878273 |
0.307 |
|
| 2006 |
Décaillot FM, Che FY, Fricker LD, Devi LA. Peptidomics of Cpefat/fat mouse hypothalamus and striatum: effect of chronic morphine administration. Journal of Molecular Neuroscience : Mn. 28: 277-84. PMID 16691015 DOI: 10.1385/Jmn:28:3:277 |
0.402 |
|
| 2006 |
Rios C, Gomes I, Devi LA. μ opioid and CB1 cannabinoid receptor interactions: Reciprocal inhibition of receptor signaling and neuritogenesis British Journal of Pharmacology. 148: 387-395. PMID 16682964 DOI: 10.1038/Sj.Bjp.0706757 |
0.494 |
|
| 2006 |
Breit A, Gagnidze K, Devi LA, Lagacé M, Bouvier M. Simultaneous activation of the delta opioid receptor (deltaOR)/sensory neuron-specific receptor-4 (SNSR-4) hetero-oligomer by the mixed bivalent agonist bovine adrenal medulla peptide 22 activates SNSR-4 but inhibits deltaOR signaling. Molecular Pharmacology. 70: 686-96. PMID 16682504 DOI: 10.1124/Mol.106.022897 |
0.788 |
|
| 2006 |
Abul-Husn NS, Devi LA. Neuroproteomics of the synapse and drug addiction. The Journal of Pharmacology and Experimental Therapeutics. 318: 461-8. PMID 16644901 DOI: 10.1124/Jpet.105.091520 |
0.62 |
|
| 2006 |
Chakraborty TR, Tkalych O, Nanno D, Garcia AL, Devi LA, Salton SR. Quantification of VGF- and pro-SAAS-derived peptides in endocrine tissues and the brain, and their regulation by diet and cold stress. Brain Research. 1089: 21-32. PMID 16631141 DOI: 10.1016/J.Brainres.2006.02.124 |
0.33 |
|
| 2006 |
Gupta A, Décaillot FM, Devi LA. Targeting opioid receptor heterodimers: strategies for screening and drug development. The Aaps Journal. 8: E153-9. PMID 16584123 DOI: 10.1208/Aapsj080118 |
0.486 |
|
| 2006 |
Pignatari GC, Rozenfeld R, Ferro ES, Oliveira L, Paiva AC, Devi LA. A role for transmembrane domains V and VI in ligand binding and maturation of the angiotensin II AT1 receptor. Biological Chemistry. 387: 269-76. PMID 16542148 DOI: 10.1515/Bc.2006.036 |
0.325 |
|
| 2006 |
Rozenfeld R, Décaillot FM, IJzerman AP, Devi LA. Heterodimers of G protein-coupled receptors as novel and distinct drug targets Drug Discovery Today: Therapeutic Strategies. 3: 437-443. DOI: 10.1016/J.Ddstr.2006.11.001 |
0.43 |
|
| 2005 |
He JC, Gomes I, Nguyen T, Jayaram G, Ram PT, Devi LA, Iyengar R. The G alpha(o/i)-coupled cannabinoid receptor-mediated neurite outgrowth involves Rap regulation of Src and Stat3. The Journal of Biological Chemistry. 280: 33426-34. PMID 16046413 DOI: 10.1074/Jbc.M502812200 |
0.304 |
|
| 2005 |
Morgan DJ, Mzhavia N, Peng B, Pan H, Devi LA, Pintar JE. Embryonic gene expression and pro-protein processing of proSAAS during rodent development. Journal of Neurochemistry. 93: 1454-62. PMID 15935061 DOI: 10.1111/J.1471-4159.2005.03138.X |
0.327 |
|
| 2005 |
Fricker AD, Rios C, Devi LA, Gomes I. Serotonin receptor activation leads to neurite outgrowth and neuronal survival. Brain Research. Molecular Brain Research. 138: 228-35. PMID 15925428 DOI: 10.1016/J.Molbrainres.2005.04.016 |
0.46 |
|
| 2005 |
Pan H, Nanno D, Che FY, Zhu X, Salton SR, Steiner DF, Fricker LD, Devi LA. Neuropeptide processing profile in mice lacking prohormone convertase-1. Biochemistry. 44: 4939-48. PMID 15779921 DOI: 10.1021/Bi047852M |
0.338 |
|
| 2005 |
Jordan JD, He JC, Eungdamrong NJ, Gomes I, Ali W, Nguyen T, Bivona TG, Philips MR, Devi LA, Iyengar R. Cannabinoid receptor-induced neurite outgrowth is mediated by Rap1 activation through G(alpha)o/i-triggered proteasomal degradation of Rap1GAPII. The Journal of Biological Chemistry. 280: 11413-21. PMID 15657046 DOI: 10.1074/Jbc.M411521200 |
0.312 |
|
| 2004 |
Rios C, Gomes I, Devi LA. Interactions between δ opioid receptors and α2A- adrenoceptors Clinical and Experimental Pharmacology and Physiology. 31: 833-836. PMID 15566403 DOI: 10.1111/J.1440-1681.2004.04076.X |
0.471 |
|
| 2004 |
Pan H, Mzhavia N, Devi LA. Endothelin converting enzyme-2: a processing enzyme involved in the generation of novel neuropeptides. Protein and Peptide Letters. 11: 461-9. PMID 15544567 DOI: 10.2174/0929866043406463 |
0.313 |
|
| 2004 |
Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE, Devi LA. A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proceedings of the National Academy of Sciences of the United States of America. 101: 5135-9. PMID 15044695 DOI: 10.1073/Pnas.0307601101 |
0.487 |
|
| 2003 |
Jordan BA, Gomes I, Rios C, Filipovska J, Devi LA. Functional interactions between mu opioid and alpha 2A-adrenergic receptors. Molecular Pharmacology. 64: 1317-24. PMID 14645661 DOI: 10.1124/Mol.64.6.1317 |
0.501 |
|
| 2003 |
Filipovska J, Gomes I, Xu W, Chen C, Liu-Chen LY, Devi LA. Recombinant opioid receptors. Structure-function relationship. Methods in Molecular Medicine. 84: 185-203. PMID 12703324 DOI: 10.1385/1-59259-379-8:185 |
0.434 |
|
| 2003 |
Gomes I, Filipovska J, Devi LA. Opioid receptor oligomerization. Detection and functional characterization of interacting receptors. Methods in Molecular Medicine. 84: 157-83. PMID 12703323 DOI: 10.1385/1-59259-379-8:157 |
0.454 |
|
| 2003 |
Mzhavia N, Pan H, Che FY, Fricker LD, Devi LA. Characterization of endothelin-converting enzyme-2. Implication for a role in the nonclassical processing of regulatory peptides. The Journal of Biological Chemistry. 278: 14704-11. PMID 12560336 DOI: 10.1074/Jbc.M211242200 |
0.327 |
|
| 2002 |
Boudarine M, Yegorov O, Sterling-Dubrovsky A, Devi LA, Berman Y. Developmental changes in opioid peptides and their receptors in Cpe(fat)/Cpe(fat) mice lacking peptide processing enzyme carboxypeptidase E. The Journal of Pharmacology and Experimental Therapeutics. 303: 1317-24. PMID 12438557 DOI: 10.1124/Jpet.102.037663 |
0.46 |
|
| 2002 |
Gomes I, Filipovska J, Jordan BA, Devi LA. Oligomerization of opioid receptors. Methods (San Diego, Calif.). 27: 358-65. PMID 12217652 DOI: 10.1016/S1046-2023(02)00094-4 |
0.497 |
|
| 2002 |
Mzhavia N, Qian Y, Feng Y, Che FY, Devi LA, Fricker LD. Processing of proSAAS in neuroendocrine cell lines. The Biochemical Journal. 361: 67-76. PMID 11742530 DOI: 10.1042/0264-6021:3610067 |
0.346 |
|
| 2002 |
Hirst RA, Smart D, Devi LA, Lambert DG. Effects of C-Terminal Truncation of the Recombinant δ-Opioid Receptor on Phospholipase C and Adenylyl Cyclase Coupling Journal of Neurochemistry. 70: 2273-2278. PMID 9603191 DOI: 10.1046/J.1471-4159.1998.70062273.X |
0.436 |
|
| 2001 |
Rios CD, Jordan BA, Gomes I, Devi LA. G-protein-coupled receptor dimerization: modulation of receptor function. Pharmacology & Therapeutics. 92: 71-87. PMID 11916530 DOI: 10.1016/S0163-7258(01)00160-7 |
0.447 |
|
| 2001 |
Devi LA. Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking. Trends in Pharmacological Sciences. 22: 532-537. PMID 11583811 DOI: 10.1016/S0165-6147(00)01799-5 |
0.408 |
|
| 2001 |
Gomes I, Jordan BA, Gupta A, Rios C, Trapaidze N, Devi LA. G protein coupled receptor dimerization: implications in modulating receptor function. Journal of Molecular Medicine (Berlin, Germany). 79: 226-42. PMID 11485015 DOI: 10.1007/S001090100219 |
0.465 |
|
| 2001 |
Che FY, Yan L, Li H, Mzhavia N, Devi LA, Fricker LD. Identification of peptides from brain and pituitary of Cpefat/Cpefat mice Proceedings of the National Academy of Sciences of the United States of America. 98: 9971-9976. PMID 11481435 DOI: 10.1073/Pnas.161542198 |
0.359 |
|
| 2001 |
Jordan BA, Trapaidze N, Gomes I, Nivarthi R, Devi LA. Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proceedings of the National Academy of Sciences of the United States of America. 98: 343-8. PMID 11134510 DOI: 10.1073/Pnas.011384898 |
0.468 |
|
| 2001 |
Mzhavia N, Berman Y, Che FY, Fricker LD, Devi LA. ProSAAS Processing in Mouse Brain and Pituitary Journal of Biological Chemistry. 276: 6207-6213. PMID 11094058 DOI: 10.1074/Jbc.M009067200 |
0.338 |
|
| 2001 |
Berman Y, Mzhavia N, Polonskaia A, Devi LA. Impaired Prohormone Convertases inCpefat/CpefatMice Journal of Biological Chemistry. 276: 1466-1473. PMID 11038363 DOI: 10.1074/Jbc.M008499200 |
0.331 |
|
| 2000 |
Guo J, Wu Y, Zhang W, Zhao J, Devi LA, Pei G, Ma L. Identification of G Protein-Coupled Receptor Kinase 2 Phosphorylation Sites Responsible for Agonist-Stimulated δ-Opioid Receptor Phosphorylation Molecular Pharmacology. 58: 1050-1056. PMID 11040053 DOI: 10.1124/Mol.58.5.1050 |
0.456 |
|
| 2000 |
Jordan BA, Cvejic S, Devi LA. Opioids and their complicated receptor complexes. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: S5-S18. PMID 11008063 DOI: 10.1016/S0893-133X(00)00143-3 |
0.492 |
|
| 2000 |
Devi LA, Brady LS. Dimerization of G-protein coupled receptors. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: S3-4. PMID 11008062 DOI: 10.1016/S0893-133X(00)00154-8 |
0.388 |
|
| 2000 |
Berman Y, Mzhavia N, Polonskaia A, Furuta M, Steiner DF, Pintar JE, Devi LA. Defective prodynorphin processing in mice lacking prohormone convertase PC2. Journal of Neurochemistry. 75: 1763-70. PMID 10987860 DOI: 10.1046/J.1471-4159.2000.0751763.X |
0.349 |
|
| 2000 |
Devi LA. G-protein-coupled receptor dimers in the lime light. Trends in Pharmacological Sciences. 21: 324-326. PMID 10973076 DOI: 10.1016/S0165-6147(00)01519-4 |
0.411 |
|
| 2000 |
Gomes I, Trapaidze N, Turndorf H, Devi LA, Bansinath M. Acute Ethanol Treatment Modulates δ Opioid Receptors in N18TG2 Cells Anesthesiology. 92: 1789-1798. PMID 10839931 DOI: 10.1097/00000542-200006000-00039 |
0.36 |
|
| 2000 |
Trapaidze N, Gomes I, Bansinath M, Devi LA. Recycling and Resensitization of Delta Opioid Receptors Dna and Cell Biology. 19: 195-204. PMID 10798443 DOI: 10.1089/104454900314465 |
0.47 |
|
| 2000 |
Trapaidze N, Gomes I, Cvejic S, Bansinath M, Devi LA. Opioid receptor endocytosis and activation of MAP kinase pathway. Molecular Brain Research. 76: 220-228. PMID 10762697 DOI: 10.1016/S0169-328X(00)00002-4 |
0.466 |
|
| 2000 |
Trapaidze N, Cvejic S, Nivarthi RN, Abood M, Devi LA. Role for C-tail residues in delta opioid receptor downregulation. Dna and Cell Biology. 19: 93-101. PMID 10701775 DOI: 10.1089/104454900314609 |
0.482 |
|
| 2000 |
Jordan BA, Cvejic S, Devi LA. Kappa opioid receptor endocytosis by dynorphin peptides. Dna and Cell Biology. 19: 19-27. PMID 10668788 DOI: 10.1089/104454900314672 |
0.492 |
|
| 2000 |
Fricker LD, McKinzie AA, Sun J, Curran E, Qian Y, Yan L, Patterson SD, Courchesne PL, Richards B, Levin N, Mzhavia N, Devi LA, Douglass J. Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing Journal of Neuroscience. 20: 639-648. PMID 10632593 DOI: 10.1523/Jneurosci.20-02-00639.2000 |
0.357 |
|
| 2000 |
Gomes I, Jordan BA, Gupta A, Trapaidze N, Nagy V, Devi LA. Heterodimerization of μ and δ Opioid Receptors: A Role in Opiate Synergy The Journal of Neuroscience. 20: RC110-RC110. DOI: 10.1523/Jneurosci.20-22-J0007.2000 |
0.484 |
|
| 2000 |
Gomes IAdS, Gupta A, Devi LA, Turndorf H, Bansinath M. Room E, 10/17/2000 9: 00 AM - 11: 00 AM (PS) Mitogen Activated Protein Kinase Pathway Is Involved in Morphine-Ketamine Interactions A-63 Anesthesiology. 93. DOI: 10.1097/00000542-200009001-00063 |
0.336 |
|
| 1999 |
Harrison C, McNulty S, Smart D, Rowbotham DJ, Grandy DK, Devi LA, Lambert DG. The effects of endomorphin-1 and endomorphin-2 in CHO cells expressing recombinant mu-opioid receptors and SH-SY5Y cells. British Journal of Pharmacology. 128: 472-8. PMID 10510460 DOI: 10.1038/Sj.Bjp.0702798 |
0.365 |
|
| 1999 |
Harrison C, Rowbotham DJ, Devi LA, Lambert DG. The effect of C-terminal truncation of the recombinant δ-opioid receptor on Cai2+ signaling European Journal of Pharmacology. 379: 237-242. PMID 10497911 DOI: 10.1016/S0014-2999(99)00507-5 |
0.385 |
|
| 1999 |
Jordan BA, Devi LA. G-protein-coupled receptor heterodimerization modulates receptor function. Nature. 399: 697-700. PMID 10385123 DOI: 10.1038/21441 |
0.486 |
|
| 1999 |
Hirota K, Okawa H, Appadu BL, Grandy DK, Devi LA, Lambert DG. Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells. Anesthesiology. 90: 174-82. PMID 9915326 DOI: 10.1097/00000542-199901000-00023 |
0.455 |
|
| 1999 |
Liuzzo JP, Petanceska SS, Devi LA. Neurotrophic factors regulate cathepsin S in macrophages and microglia: A role in the degradation of myelin basic protein and amyloid beta peptide. Molecular Medicine. 5: 334-343. DOI: 10.1007/Bf03402069 |
0.317 |
|
| 1999 |
Liuzzo JP, Petanceska SS, Moscatelli D, Devi LA. Inflammatory mediators regulate cathepsin S in macrophages and microglia: A role in attenuating heparan sulfate interactions. Molecular Medicine. 5: 320-333. DOI: 10.1007/Bf03402068 |
0.322 |
|
| 1998 |
Jordan B, Devi LA. Molecular mechanisms of opioid receptor signal transduction British Journal of Anaesthesia. 81: 12-19. PMID 9771268 DOI: 10.1093/Bja/81.1.12 |
0.479 |
|
| 1998 |
Hirota K, Appadu BL, Grandy DK, Devi LA, Lambert DG. Effect of Lidocaine on cAMP Formation with Recombinant Opioid Receptors Expressed in Chinese Hamster Ovary Cells Anesthesiology. 89: 802A. DOI: 10.1097/00000542-199809130-00108 |
0.455 |
|
| 1998 |
Hirota K, Appadu BL, Grandy DK, Devi LA, Lambert DG. Interaction of Local Anesthetics with Recombinant Opioid Receptors Expressed in Chinese Hamster Ovary Cells Anesthesiology. 89: 733A. DOI: 10.1097/00000542-199809130-00039 |
0.439 |
|
| 1997 |
Cvejic S, Devi LA. Dimerization of the delta opioid receptor: implication for a role in receptor internalization. Journal of Biological Chemistry. 272: 26959-26964. PMID 9341132 DOI: 10.1074/Jbc.272.43.26959 |
0.485 |
|
| 1997 |
Berman Y, Devi L, Spangler R, Kreek MJ, Carr KD. Chronic food restriction and streptozotocin-induced diabetes differentially alter prodynorphin mRNA levels in rat brain regions. Brain Research. Molecular Brain Research. 46: 25-30. PMID 9191075 DOI: 10.1016/S0169-328X(96)00175-1 |
0.301 |
|
| 1996 |
Fricker LD, Berman YL, Leiter EH, Devi LA. Carboxypeptidase E activity is deficient in mice with the fat mutation: Effect on peptide processing Journal of Biological Chemistry. 271: 30619-30624. PMID 8940036 DOI: 10.1074/Jbc.271.48.30619 |
0.332 |
|
| 1996 |
Trapaidze N, Keith DE, Cvejic S, Evans CJ, Devi LA. Sequestration of the δ opioid receptor: Role of the C terminus in agonist-mediated internalization Journal of Biological Chemistry. 271: 29279-29285. PMID 8910588 DOI: 10.1074/Jbc.271.46.29279 |
0.486 |
|
| 1996 |
Cvejic S, Trapaidze N, Cyr C, Devi LA. Thr, Located within the COOH-terminal Tail of the Opiate Receptor, Is Involved in Receptor Down-regulation Journal of Biological Chemistry. 271: 4073-4076. PMID 8626742 DOI: 10.1074/Jbc.271.8.4073 |
0.448 |
|
| 1995 |
Berman Y, Devi L, Carr KD. Effects of streptozotocin-induced diabetes on prodynorphin-derived peptides in rat brain regions Brain Research. 685: 129-134. PMID 7583238 DOI: 10.1016/0006-8993(95)00419-Q |
0.326 |
|
| 1995 |
Berman YL, Juliano L, Devi LA. Purification and Characterization of a Dynorphin-processing Endopeptidase Journal of Biological Chemistry. 270: 23845-23850. PMID 7559562 DOI: 10.1074/Jbc.270.40.23845 |
0.304 |
|
| 1994 |
Petanceska S, Burke S, Watson SJ, Devi L. Differential distribution of messenger RNAs for cathepsins B, L and S in adult rat brain: an in situ hybridization study. Neuroscience. 59: 729-38. PMID 8008216 DOI: 10.1016/0306-4522(94)90190-2 |
0.307 |
|
| 1994 |
Berman Y, Devi L, Carr KD. Effects of chronic food restriction on prodynorphin-derived peptides in rat brain regions Brain Research. 664: 49-53. PMID 7895045 DOI: 10.1016/0006-8993(94)91952-6 |
0.353 |
|
| 1994 |
Berman YL, Rattan AK, Carr K, Devi L. Regional distribution of neuropeptide processing endopeptidases in adult rat brain Biochimie. 76: 245-250. PMID 7819330 DOI: 10.1016/0300-9084(94)90153-8 |
0.309 |
|
| 1993 |
Petanceska S, Zikherman J, Pricker LD, Devi L. Processing of prodynorphin in BRL-3A cells, a rat liver-derived cell line: implications for the specificity of neuropeptide-processing enzymes. Molecular and Cellular Endocrinology. 94: 37-45. PMID 8375574 DOI: 10.1016/0303-7207(93)90049-P |
0.305 |
|
| 1992 |
Greco L, Daly L, Kim S, Devi L. Dynorphin-processing endopeptidase in the rat anterior pituitary lactotrophic cell line, GH4C1. Neuroendocrinology. 55: 351-356. PMID 1354336 DOI: 10.1159/000126136 |
0.344 |
|
| 1992 |
Devi L. Secretion and regulation of a neuropeptide-processing enzyme by AtT-20 cells. Endocrinology. 131: 1930-1935. PMID 1327723 DOI: 10.1210/Endo.131.4.1327723 |
0.334 |
|
| 1989 |
Devi L, Gupta P. Expression and Post‐Translational Processing of Preprodynorphin in the Rat Anterior Pituitary Cell Line, GH4C1 Journal of Neuroendocrinology. 1: 363-368. PMID 19210429 DOI: 10.1111/J.1365-2826.1989.Tb00130.X |
0.31 |
|
| 1989 |
Devi L, Gupta P, Douglass J. Expression and posttranslational processing of preprodynorphin complementary DNA in the mouse anterior pituitary cell line AtT-20 Molecular Endocrinology. 3: 1852-1860. PMID 2575215 DOI: 10.1210/Mend-3-11-1852 |
0.339 |
|
| 1989 |
McMURRAY CT, Devi L, Calavetta L, Douglass JO. Regulated expression of the prodynorphin gene in the R2C Leydig tumor cell line. Endocrinology. 124: 49-59. PMID 2462494 DOI: 10.1210/Endo-124-1-49 |
0.306 |
|
| 1986 |
Devi L, Goldstein A. Opioid and other peptides as inhibitors of leumorphin (dynorphin B-29) converting activity Peptides. 7: 87-90. PMID 3012492 DOI: 10.1016/0196-9781(86)90066-5 |
0.339 |
|
| Show low-probability matches. |